Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 7, 2011, Pages 844-849

  Carroll, L S ^a   Williams, H J ^a   Walters, J ^a   Kirov, G ^a   O'Donovan, M C ^a   Owen, M J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

3q29; DLG1; Mutation; PAK2; Schizophrenia

Indexed keywords

AMINO ACID; DLG1 PROTEIN; MEMBRANE PROTEIN; P21 ACTIVATED KINASE 2; UNCLASSIFIED DRUG;

3Q29 MICRODELETION SYNDROME; ADULT; ALLELE; ARTICLE; CHROMOSOME 3Q; CHROMOSOME 3Q29; CHROMOSOME DELETION; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; UNITED KINGDOM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; BASE SEQUENCE; CHROMOSOME DELETION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC TESTING; HUMANS; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; P21-ACTIVATED KINASES; SCHIZOPHRENIA; SYNDROME;

EID: 80052497435     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31231     Document Type: Article

References (40)

1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. 2010. A method and server for predicting damaging missense mutations. Nat Methods 7(4): 248-249.
2. Allen KM, Gleeson JG, Bagrodia S, Partington MW, MacMillan JC, Cerione RA, Mulley JC, Walsh CA. 1998. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet 20(1): 25-30.
3. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M. 1995. Autism as a strongly genetic disorder: Evidence from a British twin study. Psychol Med 25(1): 63-77.
4. Ballif BC, Theisen A, Coppinger J, Gowans GC, Hersh JH, Madan-Khetarpal S, Schmidt KR, Tervo R, Escobar LF, Friedrich CA, et al. 2008. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet 1: 8.
5. Benko S, Fantes JA, Amiel J, Kleinjan DJ, Thomas S, Ramsay J, Jamshidi N, Essafi A, Heaney S, Gordon CT, et al. 2009. Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat Genet 41(3): 359-364.
6. Bienvenu T, des Portes V, McDonell N, Carrie A, Zemni R, Couvert P, Ropers HH, Moraine C, van Bokhoven H, Fryns JP, et al. 2000. Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am J Med Genet 93(4): 294-298.
7. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, et al. 1999. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry 56(2): 162-168.
8. Clayton-Smith J, Giblin C, Smith RA, Dunn C, Willatt L. 2010. Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder. Clin Dysmorphol 19(3): 128-132.
9. Consortium WTCC. 2007. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 447(7145): 661-678.
10. Consortium IS. 2008. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455(7210): 237-241.
11. Demyanenko GP, Halberstadt AI, Rao RS, Maness PF. 2010. CHL1 cooperates with PAK1-3 to regulate morphological differentiation of embryonic cortical neurons. Neuroscience 165(1): 107-115.
12. Digilio MC, Bernardini L, Mingarelli R, Capolino R, Capalbo A, Giuffrida MG, Versacci P, Novelli A, Dallapiccola B. 2009. 3q29 Microdeletion: A mental retardation disorder unassociated with a recognizable phenotype in two mother-daughter pairs. Am J Med Genet A 149A(8): 1777-1781.
13. Dwyer S, Carroll L, Mantripragada KK, Owen MJ, O'Donovan MC, Williams NM. 2010. Mutation screening of the DTNBP1 exonic sequence in 669 schizophrenics and 710 controls using high-resolution melting analysis. Am J Med Genet B Neuropsychiatr Genet 153B(3): 766-774.
14. Flanagan SE, Patch AM, Ellard S. 2010. Using SIFT and PolyPhen to predict loss-of-function and gain-of-function mutations. Genet Test Mol Biomarkers 14(4): 533-537.
15. Fujita A, Kurachi Y. 2000. SAP family proteins. Biochem Biophys Res Commun 269(1): 1-6.
16. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, Drouin-Garraud V, Layet V, Rosier A, Briault S, Bonnet-Brilhault F, et al. 2009. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry 66(9): 947-956.
17. Hiraoka S, Kajii Y, Kuroda Y, Umino A, Nishikawa T. 2010. The development- and phencyclidine-regulated induction of synapse-associated protein-97 gene in the rat neocortex. Eur Neuropsychopharmacol 20(3): 176-186.
18. Howard MA, Elias GM, Elias LA, Swat W, Nicoll RA. 2010. The role of SAP97 in synaptic glutamate receptor dynamics. Proc Natl Acad Sci USA 10(8): 3805-3810.
19. Koolen DA, Nillesen WM, Versteeg MH, Merkx GF, Knoers NV, Kets M, Vermeer S, van Ravenswaaij CM, de Kovel CG, Brunner HG, et al. 2004. Screening for subtelomeric rearrangements in 210 patients with unexplained mental retardation using multiplex ligation dependent probe amplification (MLPA). J Med Genet 41(12): 892-899.
20. Krepischi-Santos AC, Vianna-Morgante AM, Jehee FS, Passos-Bueno MR, Knijnenburg J, Szuhai K, Sloos W, Mazzeu JF, Kok F, Cheroki C, et al. 2006. Whole-genome array-CGH screening in undiagnosed syndromic patients: Old syndromes revisited and new alterations. Cytogenet Genome Res 115(3-4): 254-261.
21. Meloni I, Muscettola M, Raynaud M, Longo I, Bruttini M, Moizard MP, Gomot M, Chelly J, des Portes V, Fryns JP, et al. 2002. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat Genet 30(4): 436-440.
22. Mendoza-Topaz C, Urra F, Barria R, Albornoz V, Ugalde D, Thomas U, Gundelfinger ED, Delgado R, Kukuljan M, Sanxaridis PD, et al. 2008. DLGS97/SAP97 is developmentally upregulated and is required for complex adult behaviors and synapse morphology and function. J Neurosci 28(1): 304-314.
23. Mulle JG, Dodd AF, McGrath JA, Wolyniec PS, Mitchell AA, Shetty AC, Sobreira NL, Valle D, Rudd MK, Satten G, et al. 2010. Microdeletions of 3q29 confer high risk for schizophrenia. Am J Hum Genet 87(2): 229-236.
24. Muscatelli F, Strom TM, Walker AP, Zanaria E, Recan D, Meindl A, Bardoni B, Guioli S, Zehetner G, Rabl W, et al. 1994. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 372(6507): 672-676.
25. Nash JE, Appleby VJ, Correa SA, Wu H, Fitzjohn SM, Garner CC, Collingridge GL, Molnar E. 2010. Disruption of the interaction between myosin VI and SAP97 is associated with a reduction in the number of AMPARs at hippocampal synapses. J Neurochem 112(3): 677-690.
26. Owen MJ, Williams HJ, O'Donovan MC. 2009. Schizophrenia genetics: Advancing on two fronts. Curr Opin Genet Dev 19(3): 266-270.
27. Purcell S, Cherny SS, Sham PC. 2003. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1): 149-150.
28. Ramensky V, Bork P, Sunyaev S. 2002. Human non-synonymous SNPs: Server and survey. Nucleic Acids Res 30(17): 3894-3900.
29. Raymond FL, Tarpey P. 2006. The genetics of mental retardation. Hum Mol Genet 15(Spec No 2): R110-R116.
30. Rossi E, Piccini F, Zollino M, Neri G, Caselli D, Tenconi R, Castellan C, Carrozzo R, Danesino C, Zuffardi O, et al. 2001. Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet 38(6): 417-420.
31. Sebat J, Levy DL, McCarthy SE. 2009. Rare structural variants in schizophrenia: One disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 25(12): 528-535.
32. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, et al. 2009. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460(7256): 753-757.
33. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, et al. 2008. Large recurrent microdeletions associated with schizophrenia. Nature 455(7210): 232-236.
34. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G, Bohman M. 1989. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 30(3): 405-416.
35. Tarpey P, Parnau J, Blow M, Woffendin H, Bignell G, Cox C, Cox J, Davies H, Edkins S, Holden S, et al. 2004. Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. Am J Hum Genet 75(2): 318-324.
36. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875): 539-543.
37. Weiss LA. 2009. Autism genetics: Emerging data from genome-wide copy-number and single nucleotide polymorphism scans. Expert Rev Mol Diagn 9(8): 795-803.
38. Willatt L, Cox J, Barber J, Cabanas ED, Collins A, Donnai D, FitzPatrick DR, Maher E, Martin H, Parnau J, et al. 2005. 3q29 microdeletion syndrome: Clinical and molecular characterization of a new syndrome. Am J Hum Genet 77(1): 154-160.
39. Zanni G, van Esch H, Bensalem A, Saillour Y, Poirier K, Castelnau L, Ropers HH, de Brouwer AP, Laumonnier F, Fryns JP, et al. 2010. A novel mutation in the DLG3 gene encoding the synapse-associated protein 102 (SAP102) causes non-syndromic mental retardation. Neurogenetics 11(2): 251-255.
40. Zhou W, Zhang L, Guoxiang X, Mojsilovic-Petrovic J, Takamaya K, Sattler R, Huganir R, Kalb R. 2008. GluR1 controls dendrite growth through its binding partner, SAP97. J Neurosci 28(41): 10220-10233.